Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
SkinBioTherapeutics PLC on Wednesday said it raised £2.6 million in total through its share placing and retail offer.
The skin health-focused life sciences company said 15.6 million shares will be issued through the placing and 733,618 shares for the retail offer. In total,16.4 million new shares will be issued, raising £2.6 million.
The share offer, first announced on Thursday last week, was priced at 16 pence each.
Shares in SkinBioTherapeutics were down 2.2% to 15.65p each in London on Wednesday morning. It currently has a market capitalisation of £24.5 million.
Following admission of the new shares, 173.1 million shares will be in issue.
SkinBioTherapeutics also on Thursday last week reported its results for the financial year that ended June 30. Its pretax loss widened to £2.7 million from £1.5 million. Revenue remained insubstantial at £74,761, versus none the year before.
‘SkinBioTherapeutics has a small team which has achieved a signi?cant amount in 12 months,’ Chief Executive Officer Stuart Ashman said. ‘Development continues apace in the post year period and another busy, exciting year is anticipated in 2023.’
By Sophie Rose, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2022 Alliance News Ltd. All Rights Reserved.